keine Finanzberatung

A · Agilent Technologies

Lab instruments and diagnostics maker

Risiko 3/10 · LOW-MODERATE RISK · lab-tools franchise · $150.86 ▲ 0.59%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $150.86
  • Market cap $42.5B
  • P/E (ttm) 29.76
  • Div yield 0.68%
  • 52-wk range $108.35 – $163.75
  • Index rank #271 / —

Wichtigste Risiken

  • Pharma and biotech funding cycles stall instrument orders (Shareholders) — MED
  • China exposure caught in trade-policy crossfire (Shareholders) — MED
  • Lab-equipment replacement cycles stretch out (Shareholders) — LOW
  • Diagnostics approvals slow the oncology growth leg (Shareholders) — LOW

Fazit

A quality lab-tools franchise at a full but not reckless price; the cycle, not the company, sets the near-term returns.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.